Drug class
Calcium Channel Blockers, intravenous
Intravenous calcium channel blockers are a parenteral drug class consisting of vascular- and cardiac-active agents formulated for rapid systemic administration. Read more about Calcium Channel Blockers, intravenous
70 drugs in this class 47 manufacturers
Drugs in Calcium Channel Blockers, intravenous
DILTIAZEM HCL
VERAPAMIL (verapamil HCl)
CARDENE IV IN SODIUM CHLORIDE (nicardipine in sodium chloride, iso-osmotic)
CARDENE IV IN DEXTROSE (nicardipine in dextrose, iso-osmotic)
CARDENE IV IN SODIUM CHLORIDE (nicardipine in sodium chloride, iso-osmotic)
CARDENE IV IN SODIUM CHLORIDE (nicardipine in sodium chloride, iso-osmotic)
CARDENE IV IN SODIUM CHLORIDE (nicardipine in sodium chloride, iso-osmotic)
CARDENE I.V. (nicardipine in sodium chloride, iso-osmotic)
Intravenous calcium channel blockers are a parenteral drug class consisting of vascular- and cardiac-active agents formulated for rapid systemic administration.
They function by selectively inhibiting transmembrane calcium ion influx via voltage-gated L-type calcium channels in vascular smooth muscle and cardiac myocytes.
This inhibition induces direct arterial vasodilation to reduce peripheral resistance, while non-dihydropyridine formulations additionally suppress sinoatrial and atrioventricular nodal conduction and myocardial contractility.
Clinically, these intravenous formulations are primarily indicated for the acute management of severe hypertension and hypertensive crises, perioperative blood pressure control, and rapid ventricular rate reduction in supraventricular tachyarrhythmias, such as atrial fibrillation and atrial flutter.
-
nih.gov
Intravenous calcium channel blockers are a parenteral drug class consisting of vascular- and cardiac-active agents formulated for rapid systemic administration This inhibition induces direct arterial vasodilation to reduce peripheral resistance, while non-dihydropyridine formulations additionally suppress sinoatrial and atrioventricular nodal conduction and myocardial contractility Clinically, these intravenous formulations are primarily indicated for the acute management of severe hypertension ...
-
nih.gov
Intravenous calcium channel blockers are a parenteral drug class consisting of vascular- and cardiac-active agents formulated for rapid systemic administration Clinically, these intravenous formulations are primarily indicated for the acute management of severe hypertension and hypertensive crises, perioperative blood pressure control, and rapid ventricular rate reduction in supraventricular tachyarrhythmias, such as atrial fibrillation and atrial flutter
-
nih.gov
They function by selectively inhibiting transmembrane calcium ion influx via voltage-gated L-type calcium channels in vascular smooth muscle and cardiac myocytes
-
nih.gov
They function by selectively inhibiting transmembrane calcium ion influx via voltage-gated L-type calcium channels in vascular smooth muscle and cardiac myocytes This inhibition induces direct arterial vasodilation to reduce peripheral resistance, while non-dihydropyridine formulations additionally suppress sinoatrial and atrioventricular nodal conduction and myocardial contractility
-
nv.gov
Clinically, these intravenous formulations are primarily indicated for the acute management of severe hypertension and hypertensive crises, perioperative blood pressure control, and rapid ventricular rate reduction in supraventricular tachyarrhythmias, such as atrial fibrillation and atrial flutter
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.